Special ReportPhosphate Homeostasis in CKD: Report of a Scientific Symposium Sponsored by the National Kidney Foundation
Section snippets
Overview
Despite guidelines recommending the restriction of dietary phosphorus in patients with CKD who manifest hyperphosphatemia or secondary hyperparathyroidism, there are few data that directly address the relationship between dietary phosphorus intake and clinical outcomes in CKD. Furthermore, the ability of dietary phosphorus modification to alter serum phosphate levels in patients with CKD has not been studied adequately. It is common to describe CKD as a state of phosphate “overload”; however,
Overview
The limited ability of interventions to reduce serum phosphate levels highlights the limitations of what is known regarding phosphate regulation. Phosphorus is an essential element for multiple cellular functions, including cell membrane structure, energy metabolism, protein modification, and as a second messenger. As such, there are duplicative mechanisms to conserve phosphate. Under stable conditions, the key determinants of phosphate balance are intestinal phosphate absorption, skeletal bone
Clinical Trial Design
The consistency of the in vitro, animal, observational, and human data certainly indicate that clinical trials aimed at intervening in phosphate regulation in an attempt to modify clinical outcomes in patients with CKD are warranted. Multiple studies have demonstrated that higher serum phosphate concentrations are associated with CVD events, CVD-related death, and all-cause death.15, 19, 23, 90, 91 Some of the available studies suggest that the relationship of higher phosphate concentrations
Summary
A substantial body of evidence suggests that disordered phosphate homeostasis is central to CKD-MBD. Phosphate dysregulation begins early in the course of CKD and is associated with maladaptive CV changes and loss of bone structural integrity. Clinical consequences may include further loss of kidney function, CV events, and fractures. These disturbances in phosphate metabolism, which do not necessarily lead to an increase in total-body phosphate, are mediated by a series of complex changes to
Acknowledgements
The NKF acknowledges CM&D Pharma, Cytochroma, Sanofi, and Vifor for their support of the conference; Kerry Willis, PhD, and Tom Manley of the NKF, who assisted in meeting logistics and manuscript preparation; and Doug Chauncey at XTEC media, who assisted with graphic design.
Conference participants are as follows. Stephen Appelbee, London, UK; Joseph Bender, MD, Cambridge, MA; Geoffrey Block, MD, Denver, CO; Mona Calvo, PhD, Laurel, MD; Ricardo Carvajal, MS, JD, Washington, DC; Dolph
References (102)
- et al.
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Kidney Int
(2011) - et al.
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease
Kidney Int
(2007) The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder
Kidney Int
(2011)- et al.
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study
Am J Kidney Dis
(1998) - et al.
Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III)
Am J Kidney Dis
(2009) - et al.
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease
Kidney Int
(2013) - et al.
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?
Am J Clin Nutr
(2008) - et al.
Diet modification effects on serum and urine phosphorus levels: the Modification of Diet in Renal Disease Study
Am J Kidney Dis
(2013) - et al.
Dietary phosphorus is associated with left ventricular mass: the Multi-Ethnic Study of Atherosclerosis
Kidney Int
(2013) - et al.
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease
J Ren Nutr
(2013)
New evidence for the phosphorus-lowering effects of niacin
Am J Kidney Dis
Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients
Am J Kidney Dis
Physiological responses of human adults to foods containing phosphate additives
J Nutr
Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency
Gastroenterology
Phosphate and FGF-23
Kidney Int Suppl
Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23
Mol Cell Endocrinol
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
Kidney Int
Phosphate and klotho
Kidney Int Suppl
Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies
Am J Kidney Dis
Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis
Am J Hum Genet
Intestinal phosphate absorption in a model of chronic renal failure
Kidney Int
Serum phosphorus and cardiovascular mortality in type 2 diabetes
Am J Med
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study
Am Heart J
Phosphorus levels are associated with subclinical atherosclerosis in the general population
Atherosclerosis
Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study
Am J Kidney Dis
Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA)
J Ren Nutr
Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study
Am J Kidney Dis
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
Kidney Int Suppl
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
J Clin Invest
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitrol deficiency in chronic kidney disease
J Am Soc Nephrol
Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism
Clin J Am Soc Nephrol
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23
Annu Rev Med
Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the “trade-off” hypothesis
Clin J Am Soc Nephrol
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
J Am Soc Nephrol
Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization
Clin J Am Soc Nephrol
Association of serum phosphate with vascular and valvular calcification in moderate CKD
J Am Soc Nephrol
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition
J Am Soc Nephrol
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
Arch Intern Med
Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community
Eur J Heart Fail
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
Nephrol Dial Transplant
Phosphate levels and cardiovascular disease in the general population
Clin J Am Soc Nephrol
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
Circulation
Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake
Semin Dial
Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?
Semin Dial
Chronic Kidney Disease: Early Identification and Managment of Chronic Kidney Disease in Adults in Primary and Secondary CareCG73
Serum phosphate levels and mortality risk among people with chronic kidney disease
J Am Soc Nephrol
Phosphate levels—time for a rethink?
Nephrol Dial Transplant
Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorusImplications for the renal production of 1,25-dihydroxyvitamin D
J Clin Invest
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
Clin J Am Soc Nephrol
Mineral metabolism parameters throughout chronic kidney disease stages 1-5—achievement of K/DOQI target ranges
Nephrol Dial Transplant
Cited by (0)
Originally published online June 13, 2013.